Joint hypothesis: a novel concept of cholesterol, inflammation, and atherosclerosis
-
摘要: 动脉粥样硬化(AS)之胆固醇学说已深入人心，炎症作为AS发病的重要机制之一也倍受关注。新近Nature杂志刊出哈佛大学Peter Libby教授的文章，其核心学术思想之一是将AS的胆固醇理论和炎症学说“融合”一体，认为二者缺一不可。作者读后颇有感悟，草起此文，与读者共享。Abstract: It is well-known that atherosclerosis (AS) is a cholesterol-mediated disease, strongly associated with inflammation, to which close attention is widely paid. More recently, an interesting paper written by Peter Libby, a professor at Harvard University, was published in Nature. One of the core academic points is the combined theory of cholesterol and inflammation in the development of AS. I have several reactions after reading this wonderful manuscript and now present them in this journal to enjoy it with others.
-
Key words:
- atherosclerosis /
- cholesterol /
- inflammation /
- joint hypothesis
-
-
[1] Libby P. The changing landscape of atherosclerosis[J]. Nature, 2021, 592(7855): 524-533. doi: 10.1038/s41586-021-03392-8
[2] Libby P. Inflammation in atherosclerosis[J]. Nature, 2002, 420(6917): 868-874. doi: 10.1038/nature01323
[3] Li JJ, Fang CH. Atheroscleritis is a more rational term for the pathological entity currently known as atherosclerosis[J]. Med Hypotheses, 2004, 63(1): 100-102. doi: 10.1016/j.mehy.2004.01.029
[4] Li JJ, Fang CH. C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases[J]. Med Hypotheses, 2004, 62(4): 499-506. doi: 10.1016/j.mehy.2003.12.014
[5] 李建军. 心血管病进展与2011回顾炎症与冠状动脉粥样硬化性疾病研究进展[J]. 心血管病学进展, 2012, 33(1): 10-13. doi: 10.3969/j.issn.1004-3934.2012.01.004
[6] Amento EP, Ehsani N, Palmer H, et al. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells[J]. Arterioscler Thromb, 1991, 11(5): 1223-1230. doi: 10.1161/01.ATV.11.5.1223
[7] Rocha VZ, Folco EJ, Sukhova G, et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity[J]. Circ Res, 2008, 103(5): 467-476. doi: 10.1161/CIRCRESAHA.108.177105
[8] Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein[J]. N Engl J Med, 2008, 359(21): 2195-207. doi: 10.1056/NEJMoa0807646
[9] Ridker PM, Everett BM, Thuren T, et al. Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease[J]. N Engl J Med, 2017, 377(12): 1119-1131. doi: 10.1056/NEJMoa1707914
[10] Wu NQ, Shi HW, Li JJ. Proprotein Convertase Subtilisin/Kexin Type 9 and Inflammation: An Updated Review[J]. Front Cardiovasc Med, 2022, 9: 763516. doi: 10.3389/fcvm.2022.763516
[11] Nidorf SM, Eikelborn JW, Budgeon CA, et al. Low-dose colchicine for secondary prevention of cardiovascular disease[J]. J Am Coll Cardiol, 2013, 61(4): 404-410. doi: 10.1016/j.jacc.2012.10.027
-
计量
- 文章访问数: 1638
- PDF下载数: 714
- 施引文献: 0
下载: